Pfizer's COVID antiviral, bankrolled by Biden administration, doesn't help high-risk adults: study
New England Journal of Medicine lets Anthony Fauci and his onetime deputy play down results in editorial alongside study from U.K., Canada trials. Critics suspect profit motive played role in long-delayed publication.
Original Source
Read the full article at Justthenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.